Ignite Creation Date:
2025-12-24 @ 2:40 PM
Ignite Modification Date:
2026-02-02 @ 9:47 PM
Study NCT ID:
NCT03419559
Status:
WITHDRAWN
Last Update Posted:
2019-04-16
First Post:
2018-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer
Sponsor:
Iovance Biotherapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Small Cell Lung Cancer | View |